Astrocytic junctional adhesion molecule-A regulates T-cell entry past the glia limitans to promote central nervous system autoimmune attack.
Astrocytic junctional adhesion molecule-A regulates T-cell entry past the glia limitans to promote central nervous system autoimmune attack.
复制标题
DOI:
10.1093/braincomms/fcac044
复制
发表时间:
2022
影响因子:
4.8
通讯作者:
Horng S
中科院分区:
文献类型:
--
作者:
Amatruda M;Chapouly C;Woo V;Safavi F;Zhang J;Dai D;Therattil A;Moon C;Villavicencio J;Gordon A;Parkos C;Horng S
Contact-mediated interactions between the astrocytic endfeet and infiltrating immune cells within the perivascular space are underexplored, yet represent potential regulatory check-points against CNS autoimmune disease and disability. Reactive astrocytes upregulate junctional adhesion molecule-A, an immunoglobulin-like cell surface receptor that binds to T cells via its ligand, the integrin, lymphocyte function-associated antigen-1. Here, we tested the role of astrocytic junctional adhesion molecule-A in regulating CNS autoinflammatory disease. In cell co-cultures, we found that junctional adhesion molecule-A-mediated signalling between astrocytes and T cells increases levels of matrix metalloproteinase-2, C–C motif chemokine ligand 2 and granulocyte-macrophage colony-stimulating factor, pro-inflammatory factors driving lymphocyte entry and pathogenicity in multiple sclerosis and experimental autoimmune encephalomyelitis, an animal model of CNS autoimmune disease. In experimental autoimmune encephalomyelitis, mice with astrocyte-specific JAM-A deletion (mGFAP:CreJAM-Afl/fl) exhibit decreased levels of matrix metalloproteinase-2, reduced ability of T cells to infiltrate the CNS parenchyma from the perivascular spaces and a milder histopathological and clinical course of disease compared with wild-type controls (JAM-Afl/fl). Treatment of wild-type mice with intraperitoneal injection of soluble junctional adhesion molecule-A blocking peptide decreases the severity of experimental autoimmune encephalomyelitis, highlighting the potential of contact-mediated astrocyte–immune cell signalling as a novel translational target against neuroinflammatory disease. Amatruda et al. report that the astrocytic immune cell receptor, junctional adhesion molecule-A, increases levels of matrix metalloproteinase-2 and promotes T-cell entry into the CNS during autoimmune attack. Blocking contact-mediated astrocyte immune cell signals represents a novel therapeutic approach against multiple sclerosis and other CNS autoinflammatory diseases.
登录
查看更多内容
影响因子:
12.7
作者:
Gharagozloo M;Smith MD;Jin J;Garton T;Taylor M;Chao A;Meyers K;Kornberg MD;Zack DJ;Ohayon J;Calabresi BA;Reich DS;Eberhart CG;Pardo CA;Kemper C;Whartenby KA;Calabresi PA
通讯作者:
Calabresi PA
影响因子:
15.9
作者:
Horng, Sam;Therattil, Anthony;John, Gareth R.
通讯作者:
John, Gareth R.
影响因子:
8
作者:
Flemming, Sven;Luissint, Anny-Claude;Parkos, Charles A.
通讯作者:
Parkos, Charles A.
影响因子:
5.3
作者:
Bhowmick, Saurav;D'Mello, Veera;Abdul-Muneer, P. M.
通讯作者:
Abdul-Muneer, P. M.
DOI:
10.4049/jimmunol.1701484
发表时间:
2018-02-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Duncker PC;Stoolman JS;Huber AK;Segal BM
通讯作者:
Segal BM